Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
Zhang M, Mathews Griner LA, Ju W, Duveau DY, Guha R, Petrus MN, Wen B, Maeda M, Shinn P, Ferrer M, Conlon KD, Bamford RN, O'Shea JJ, Thomas CJ, Waldmann TA. Zhang M, et al. Among authors: bamford rn. Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12480-5. doi: 10.1073/pnas.1516208112. Epub 2015 Sep 22. Proc Natl Acad Sci U S A. 2015. PMID: 26396258 Free PMC article.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.
Lymphokine receptor-directed therapy: a model of immune intervention.
Waldmann TA, Grant A, Tendler C, Greenberg S, Goldman C, Bamford R, Junghans RP, Nelson D. Waldmann TA, et al. J Clin Immunol. 1990 Nov;10(6 Suppl):19S-28S; discussion 28S-29S. doi: 10.1007/BF00918688. J Clin Immunol. 1990. PMID: 2081786 Review.
A T-cell line with an unusual phenotype.
Chan WC, Link S, Srinivasan A, Bamford R, Waldmann TA. Chan WC, et al. Cancer. 1989 Nov 1;64(9):1859-66. doi: 10.1002/1097-0142(19891101)64:9<1859::aid-cncr2820640918>3.0.co;2-w. Cancer. 1989. PMID: 2551476
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA, Brechbiel MW, Jaffe ES, Fleisher TA, Goldman CK, Top LE, Bamford R, Zaknoen E, Roessler E, Kasten-Sportes C, England R, Litou H, Johnson JA, Jackson-White T, Manns A, Hanchard B, Junghans RP, Nelson DL. Waldmann TA, et al. Blood. 1995 Dec 1;86(11):4063-75. Blood. 1995. PMID: 7492762 Free article. Clinical Trial.
A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. Burton JD, et al. Among authors: bamford rn. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4935-9. doi: 10.1073/pnas.91.11.4935. Proc Natl Acad Sci U S A. 1994. PMID: 8197160 Free PMC article.
The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. Bamford RN, et al. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4940-4. doi: 10.1073/pnas.91.11.4940. Proc Natl Acad Sci U S A. 1994. PMID: 8197161 Free PMC article.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Ann N Y Acad Sci. 1993 Jun 23;685:603-10. doi: 10.1111/j.1749-6632.1993.tb35923.x. Ann N Y Acad Sci. 1993. PMID: 8363269 Review. No abstract available.
38 results